Bradley S. King

Life Sciences

• Blackstone in Precision Medicine Group’s major investment and recapitalization
• Concordia Healthcare in its $1.2 billion acquisition of the commercial assets of Covis
• LabCorp in its $6.1 billion acquisition of Covance
• Nexus Pharmaceuticals in the sale of its injectable medicine manufacturing facility to Eli Lilly and Company
• Seagen (formerly Seattle Genetics) in its:
• $43 billion acquisition by Pfizer; and
• $614 million acquisition of Cascadian Therapeutics
• Sumitomo Pharma America in the transfer of its wholly-owned subsidiary, Spirovant Sciences, to Ruagen Bio, Inc., a company newly established by Spirovant's management
• Teva Pharmaceutical Industries in its $40.5 billion acquisition of Allergan Generics
• Valeant in its $15.8 billion acquisition of Salix
• Verily Life Sciences in:
  • a transaction whereby Swiss Re exchanged its investment in Granular Insurance for an equity stake in Verily; and
  • its $1 billion investment round led by parent company Alphabet

Digital & Technology

• Ares Management in its acquisition of a majority interest in Kuecker Pulse Integration
• AT&T in its $1.875 billion acquisition of Nextel Mexico
• DigitalBridge (formerly Colony Capital) in its:
  • acquisition of Wafra’s 31.5% ownership in DigitalBridge’s investment management subsidiary for $800 million; and
  • agreement to acquire AMP Capital’s global infrastructure equity investment management business (comprising four investment funds with $5.5 billion in fee-earning assets under management) for $328 million
• Forge Global Holdings in its $660 million pending acquisition by The Charles Schwab Corporation
• Harris Corporation in its $35 billion merger with L3 Technologies to form L3Harris Technologies
• Springcoast Capital Partners in its investments in Acronis, CallMiner, Deepwatch, Egnyte, GumGum, Komodo Health, Nanit, Overhaul and Peek

Energy & Industrials

• California Resources Corporation in its:
• $2.1 billion all-stock combination with Aera Energy; and
• $717 million all-stock combination with Berry Corporation
• DS Smith in its $585 million sale of the Plastics division to Olympus Partners
• Enbridge in its $43 billion acquisition of Spectra Energy
• Garrett Motion in its stalking horse purchase agreement with KPS Capital Partners to buy its business for $2.6 billion prior to filing for bankruptcy protection
• Standard Industries in its:
  • $7 billion acquisition of W. R. Grace & Co.; and
  • acquisition of FT Synthetics

Consumer & Retail

• Ares and Ontario Teachers’ Pension Plan in their acquisition of a majority interest in TricorBraun
• Kraft Foods Group in its $55 billion merger with H.J. Heinz Company to create The Kraft Heinz Company
• Pineland Farms in its sale to Bob Evans Foods
• TricorBraun, a portfolio company of Ares and Ontario Teachers’ Pension Plan, in its:
• acquisition of Veritiv Containers; and
• acquisition of Zuckerman Honickman

Real Estate

• Cadillac Fairview in its exchange of interests in five shopping centers for an 11% interest in The Macerich Company
• Cole Real Estate Investments in its listing on the New York Stock Exchange and its $250 million self tender
• Forest City Realty Trust in its:
  • $11.4 billion acquisition by Brookfield Asset Management;
  • reorganization into a REIT;
  • agreement to declassify its common stock; and
  • settlement with Starboard Value and Scopia Capital
• The special committee of the board of directors of Griffin-American Healthcare REIT IV in its acquisition of Griffin-American Healthcare REIT III